
Please try another search
By Leroy Leo
(Reuters) -Abbott Laboratories said on Thursday it is actively developing a test for monkeypox, as the disease spreads in various countries.
The company will provide the test kits to partners of its Pandemic Defense Coalition, a network of scientific and public health partnerships aimed at identifying future pandemic threats, an Abbott spokesperson told Reuters.
"As the situation evolves, we will take steps to address additional testing needs," the spokesperson said.
Abbott's announcement comes on a day when the Centers for Diseases Control and Prevention (CDC) confirmed it has identified nine monkeypox cases in seven U.S. states.
Globally, more than 200 confirmed or suspected infections have been recorded in around 20 countries where monkeypox is not endemic. Most of these cases have been found in Europe.
Abbott is the second company to announce its development of monkeypox tests following Roche's announcement on Wednesday.
By Sandra Sebastian, Tamara Corro and Sofia Menchu NAHUALA, Guatemala/ATEXQUILAPAN, Mexico (Reuters) - Some of the youngest migrants thought to have died in a suffocating trailer...
By Max Hunder and Tom Balmforth KYIV (Reuters) -A Russian missile strike in Ukraine's southern port of Odesa early on Friday killed at least 10 people, a regional official said, a...
By Kanishka Singh (Reuters) - Uvalde schools police chief Pete Arredondo, who is also a member of the city council, missed a second council meeting on Thursday at which he was to...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.